Employment Verification for Global Blood Therapeutics.

About Global Blood Therapeutics

Global Blood Therapeutics (GBT) is a biotechnology company focused on developing and commercializing innovative treatments for people living with sickle cell disease (SCD). The company’s lead product candidate, Oxbryta (voxelotor) tablets, targets the root cause of SCD by increasing hemoglobin’s affinity for oxygen. This therapy has received FDA approval for the treatment of sickle cell disease in patients aged 12 years and older. GBT is also developing other therapeutic candidates for SCD, including GBT021601, a next-generation oral once-daily therapy, and inclacumab, an anti-P-selectin monoclonal antibody. Additionally, the company is advancing development programs in other hemolytic anemias, such as beta thalassemia and myelodysplastic syndromes. GBT was founded in 2011 and is headquartered in South San Francisco, California. The company has a global presence, with operations in the United States, Europe, and Asia. Its mission is to improve the lives of people living with SCD by discovering, developing, and delivering transformative therapies.

The information on this page is not an endorsement of Truv’s services by Global Blood Therapeutics and is meant to be purely informational.

Verify Global Blood Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.